Factset Research Systems Inc: Form 10-Q for the period ended Feb 28, 2013
Filed with the SEC on Apr 9, 2013 and accepted by EDGAR at Apr 9, 2013, 15:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-02-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-12-01 to 2013-02-28 | $213.1m | us-gaap:Revenues |
| Revenue | 6 months2012-09-01 to 2013-02-28 | $424.2m | us-gaap:Revenues |
| Cost of revenue | 3 months2012-12-01 to 2013-02-28 | $75.8m | us-gaap:CostOfServices |
| Cost of revenue | 6 months2012-09-01 to 2013-02-28 | $149.4m | us-gaap:CostOfServices |
| Selling, general and administrative | 3 months2012-12-01 to 2013-02-28 | $81.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2012-09-01 to 2013-02-28 | $147.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-12-01 to 2013-02-28 | $56.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-09-01 to 2013-02-28 | $127.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-12-01 to 2013-02-28 | $12.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-09-01 to 2013-02-28 | $33.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-12-01 to 2013-02-28 | $44.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2012-09-01 to 2013-02-28 | $94.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-12-01 to 2013-02-28 | $1.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-09-01 to 2013-02-28 | $2.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-12-01 to 2013-02-28 | $1.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-09-01 to 2013-02-28 | $2.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-12-01 to 2013-02-28 | 44,455,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-09-01 to 2013-02-28 | 44,788,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-09-01 to 2013-02-28 | $97.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2012-12-01 to 2013-02-28 | $3.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2012-09-01 to 2013-02-28 | $9.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2012-09-01 to 2013-02-28 | $27.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2012-09-01 to 2013-02-28 | $139.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-02-28 | $151.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-02-28 | $284.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-02-28 | $670.0m | us-gaap:Assets |
| Current liabilities | At period end2013-02-28 | $94.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-02-28 | $122.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-02-28 | $547.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-13-004187. Last ingested by Listed: Nov 11, 2026, 01:02 ET. Listed shows no prices and gives no investment advice.